Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The devil is in the details: observational study finds better outcomes for uncomplicated cystitis treated with fluoroquinolones

Clinical Microbiology and Infection(2020)10.1016/j.cmi.2020.01.013Source: DataRank Database

The devil is in the details: observational study finds better outcomes for uncomplicated cystitis treated with fluoroquinolones is a research paper published in Clinical Microbiology and Infection (2020). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.14)OA: bronzeTopics (28)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Jason L. Salemi ORCID,Barbara W. Trautner ORCID,Larissa Grigoryan

Live enrichment

PubMed:31968271 OpenAlex:https://openalex.org/W2999661066

Houston Veterans Affairs Health Services Research & Development Center for Innovations in Quality, effectiveness and Safety

Grant: CIN 13-413

Veterans Affairs Health Services Research and Development

Agency for Healthcare Research and Quality

Centers for Disease Control and Prevention

US National Institute of Health

Zambon Pharmaceuticals, Italy

Paratek pharmaceuticals

Zambon Pharmaceuticals

FWCI

0.14

Citation Percentile

0.4%

Citation Trend

2020

2025

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.clinicalmicrobiologyandinfection.com/article/S1198743X20300380/pdf

publisherhttp://www.clinicalmicrobiologyandinfection.com/article/S1198743X20300380/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1198743X20300380?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1198743X20300380?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cmi.2020.01.013

Fields of Study

Urinary Tract Infections ManagementUrinary Bladder and Prostate ResearchPelvic floor disorders treatmentsAnti-Bacterial AgentsCystitisFemaleFluoroquinolonesHumansObservational Studies as TopicPractice Guidelines as TopicTreatment OutcomeUrinary Tract Infections

MeSH Terms

Anti-Bacterial AgentsCystitisFemaleHumansUrinary Tract InfectionsTreatment OutcomePractice Guidelines as TopicFluoroquinolonesObservational Studies as Topic

Keywords

Observational studyMedicineInternal medicineUrinary tract infectionsFluoroquinolonesCystitisAntibiotic Stewardship